WILMINGTON – Prelude Therapeutics announced Monday, Oct. 28, that it will expand in Delaware, adding up to 49 biotech positions by 2022 and investing $5 million in expanded lab and office space in the Wilmington ...
© 2022 Delaware Business Times
Holiday flash sale! Subscribe to Delaware Business Times and save 50%.
Limited time offer. New subscribers only.